The ClinicianThe ClinicianКлиницист1818-83382412-8775Publishing House ABV Press4510.17650/1818-8338-2013-1-64-69PHARMACOTHERAPYФАРМАКОТЕРАПИЯLUMBAGO: ENHANCING THE EFFICIENCY OF THERAPYПОЯСНИЧНАЯ БОЛЬ – ПОВЫШЕНИЕ ЭФФЕКТИВНОСТИ ТЕРАПИИKamchatnovP. R.КамчатновП. Р.
Russian Federation
pavkam7@gmail.comUmarovaKh. Ya.УмароваХ. Я.
Russian Federation

медицинский факультет

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia,ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава РоссииMedical Faculty, Chechen State UniversityФГБОУ ВПО «Чеченский государственный университет»150120137164691507201415072014Copyright ©; 2013, Kamchatnov P.R., Umarova K.Y.Copyright ©; 2013, Камчатнов П.Р., Умарова Х.Я.2013Kamchatnov P.R., Umarova K.Y.Камчатнов П.Р., Умарова Х.Я.https://creativecommons.org/licenses/by/4.0https://klinitsist.abvpress.ru/Klin/article/view/45

Lumbago is an exceptionally common syndrome associated with sizable material costs, high recurrence incidence rates, and a risk for chronic pain. While managing a patient with lumbago, it is necessary to exclude the potential causes of secondary pain syndrome, including injuries, neoplasms, local infections, and somatic diseases. Nonsteroidal anti-inflammatory drugs and analgesics, which are responsible for side effects in a number of cases, have a good analgesic effect. Concurrently with their use, Milgamma, a neutropic vitamin B complex, produces a higher antinociceptive effect, a less need for analgesic drugs, shorter treatment, and more prolonged remission.

Поясничная боль – исключительно распространенный синдром, ассоциированный со значительными материальными затратами, высокой частотой рецидивов, риском формирования хронической боли. При ведении пациента с поясничной болью необходимо исключить потенциальные причины вторичного характера болевого синдрома, включая травмы, новообразования, локальные инфекционные поражения, соматические заболевания. Хорошим обезболивающим эффектом обладают нестероидные противовоспалительные препараты и анальгетики, применение которых в ряде случаев сопряжено с развитием побочных эффектов. Одновременное с ними применение препарата Мильгамма – комплекса нейротропных витаминов группы В – обеспечивает повышение противоболевого эффекта, снижение потребности в применении анальгетических препаратов, сокращение сроков лечения и увеличение продолжительности ремиссии.

lumbagodiscogenic radiculopathynonsteroidal anti-inflammatory drugsB-group vitaminsMilgammaпоясничная больдискогенная радикулопатиянестероидные противовоспалительные препаратывитамины группы ВМильгамма1. Hall H., McIntosh G. Low back pain (acute). Clin Evid (Online). 2008;2008. pii: 1102. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907975/.Hall H., McIntosh G. Low back pain (acute). Clin Evid (Online). 2008;2008. pii: 1102. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907975/.2. Le T.K., Montejano L.B., Cao Z. et al. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Res 2012;(5):23–30.Le T.K., Montejano L.B., Cao Z. et al. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Res 2012;(5):23–30.3. Lawrence R.С., Felson D.Т., Helmick C.G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58(1):26–35.Lawrence R.С., Felson D.Т., Helmick C.G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58(1):26–35.4. Scott N.А., Moga C., Harstall C. Managing low back pain in the primary care setting: the know-do gap. Pain Res Manag 2010;15(6):392–400.Scott N.А., Moga C., Harstall C. Managing low back pain in the primary care setting: the know-do gap. Pain Res Manag 2010;15(6):392–400.5. Likar R., Kager I., Obmann M. et al. Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster. Int J Gen Med 2012;(5):689–92.Likar R., Kager I., Obmann M. et al. Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster. Int J Gen Med 2012;(5):689–92.6. Sharma H.А., Gupta R., Olivero W. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Res 2011;(4):401–5.Sharma H.А., Gupta R., Olivero W. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Res 2011;(4):401–5.7. Koes B.W., van Tulder M., Lin С.W. et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J 2010;19(12):2075–94.Koes B.W., van Tulder M., Lin С.W. et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J 2010;19(12):2075–94.8. Rihn J.А., Hilibrand A.S., Radcliff K. et al. Duration of Symptoms Resulting from Lumbar disc herniation: effect on treatment outcomes: analysis of the Spine Patient Outcomes Research Trial (SPORT). J Bone Joint Surg Am 2011;93(20):1906–14.Rihn J.А., Hilibrand A.S., Radcliff K. et al. Duration of Symptoms Resulting from Lumbar disc herniation: effect on treatment outcomes: analysis of the Spine Patient Outcomes Research Trial (SPORT). J Bone Joint Surg Am 2011;93(20):1906–14.9. Яхно Н.Н. Боль. Руководство для студентов и врачей. М.: МЕДпресс-информ, 2010.Яхно Н.Н. Боль. Руководство для студентов и врачей. М.: МЕДпресс-информ, 2010.10. Pillastrini P., Gardenghi I., Bonetti F. et al. An updated overview of clinical guidelines for chronic low back pain management in primary care. Joint Bone Spine 2012;79(2):176–85.Pillastrini P., Gardenghi I., Bonetti F. et al. An updated overview of clinical guidelines for chronic low back pain management in primary care. Joint Bone Spine 2012;79(2):176–85.11. White A.Р., Arnold P.М., Norvell D.С. et al. Pharmacologic management of chronic low back pain: synthesis of the evidence. Spine (Phila Pa 1976) 2011;36(21 Suppl):S131–43.White A.Р., Arnold P.М., Norvell D.С. et al. Pharmacologic management of chronic low back pain: synthesis of the evidence. Spine (Phila Pa 1976) 2011;36(21 Suppl):S131–43.12. Ferguson F., Holdsworth L., Rafferty D. Low back pain and physiotherapy use of red flags: the evidence from Scotland. Physiotherapy 2010;96(4):282–8.Ferguson F., Holdsworth L., Rafferty D. Low back pain and physiotherapy use of red flags: the evidence from Scotland. Physiotherapy 2010;96(4):282–8.13. Chou R., Qaseem A., Owens D. et al. Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med 2011;154(3):181–9.Chou R., Qaseem A., Owens D. et al. Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med 2011;154(3):181–9.14. Dagenais S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008;8(1):8–20.Dagenais S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008;8(1):8–20.15. Delitto A., George S.Z., Van Dillen L.R. et al.; Orthopaedic Section of the American Physical Therapy Association. Low back pain. J Orthop Sports Phys Ther 2012;42(4):A1–57.Delitto A., George S.Z., Van Dillen L.R. et al.; Orthopaedic Section of the American Physical Therapy Association. Low back pain. J Orthop Sports Phys Ther 2012;42(4):A1–57.16. Guevara-López U., Covarrubias-Gómez A., Elías-Dib J. et al. Practice guidelines for the management of low back pain. Consensus Group of Practice Parameters to Manage Low Back Pain. CirGuevara-López U., Covarrubias-Gómez A., Elías-Dib J. et al. Practice guidelines for the management of low back pain. Consensus Group of Practice Parameters to Manage Low Back Pain. CirCir 2011;79(3):264–79.17. Caldwell B., Aldington S., Weatherall M. et al. Risk of cardiovascular events and celecoxib: a systematic review and metaanalysis. J R Soc Med 2006;99(3):132–40.Caldwell B., Aldington S., Weatherall M. et al. Risk of cardiovascular events and celecoxib: a systematic review and metaanalysis. J R Soc Med 2006;99(3):132–40.18. McGettigan P., Henry D. Use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med 2013;10(2):e1001388.McGettigan P., Henry D. Use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med 2013;10(2):e1001388.19. Lapi F., Azoulay L., Yin H. et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with nonsteroidal anti-inflammatory drugs and risk ofLapi F., Azoulay L., Yin H. et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with nonsteroidal anti-inflammatory drugs and risk ofacute kidney injury: Nested case-control study. BMJ 2013;(346):e8525.20. Kuwabara S., Nakazawa R., Azuma N. et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999;38(6):472–5.Kuwabara S., Nakazawa R., Azuma N. et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999;38(6):472–5.21. Caram-Salas N.L., Reyes-García G., Medina-Santillán R., Granados-Soto V. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone. Pharmacology 2006;77(2):53–62.Caram-Salas N.L., Reyes-García G., Medina-Santillán R., Granados-Soto V. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone. Pharmacology 2006;77(2):53–62.22. Stabler S.P. Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013;368(2):149–60.Stabler S.P. Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013;368(2):149–60.23. Wang Z.B., Gan Q., Rupert R.L. et al. Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury. PainWang Z.B., Gan Q., Rupert R.L. et al. Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury. Pain2005;114(1–2):266–77.;114(1–2):266–77.24. Pawlak R., Parrott S.J, Raj S. et al. How prevalent is vitamin B(12) deficiency among vegetarians? Nutr Rev 2013;71(2):14–8.Pawlak R., Parrott S.J, Raj S. et al. How prevalent is vitamin B(12) deficiency among vegetarians? Nutr Rev 2013;71(2):14–8.25. Mibielli M., Geller M., Cohen J. et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin 2009;25(11):2589–99.Mibielli M., Geller M., Cohen J. et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin 2009;25(11):2589–99.26. Chiu C.K., Low T.H., Tey Y. et al. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singapore Med J 2011;52(12):868–73.Chiu C.K., Low T.H., Tey Y. et al. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singapore Med J 2011;52(12):868–73.27. Левин О.С., Мосейкин И.А. Комплекс витаминов группы B (мильгамма) в лечении дискогенной пояснично-крестцовой радикулопатии. Журн неврол и психиатр 2009;109(10):30–5.Левин О.С., Мосейкин И.А. Комплекс витаминов группы B (мильгамма) в лечении дискогенной пояснично-крестцовой радикулопатии. Журн неврол и психиатр 2009;109(10):30–5.28. Батышева Т.Т., Отческая О.В., Хозов а А.А. и др. Эффективность применения комбинации препаратов артрозан и комбилипен у пациентов с острой болью в нижней части спины. Журн неврол и психиатр 2011;111(9 Часть 2):41–4.Батышева Т.Т., Отческая О.В., Хозов а А.А. и др. Эффективность применения комбинации препаратов артрозан и комбилипен у пациентов с острой болью в нижней части спины. Журн неврол и психиатр 2011;111(9 Часть 2):41–4.